M
Mary Beth F. Son
Researcher at Boston Children's Hospital
Publications - 99
Citations - 6132
Mary Beth F. Son is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 23, co-authored 64 publications receiving 3102 citations. Previous affiliations of Mary Beth F. Son include Harvard University.
Papers
More filters
Journal ArticleDOI
Multisystem Inflammatory Syndrome in U.S. Children and Adolescents.
Leora R. Feldstein,Leora R. Feldstein,Erica B. Rose,Erica B. Rose,Steven M. Horwitz,Jennifer P. Collins,Margaret M Newhams,Mary Beth F. Son,Jane W. Newburger,Lawrence C. Kleinman,Sabrina M. Heidemann,Amarilis A. Martin,Aalok R. Singh,Simon Li,Keiko M. Tarquinio,Preeti Jaggi,Matthew E. Oster,Sheemon P. Zackai,Jennifer K. Gillen,Adam J. Ratner,Rowan Walsh,Julie C. Fitzgerald,Michael A. Keenaghan,Hussam Alharash,Sule Doymaz,Katharine N. Clouser,John S. Giuliano,Anjali Gupta,Robert M. Parker,Aline B Maddux,Vinod Havalad,Stacy Ramsingh,Hulya Bukulmez,Tamara T. Bradford,Lincoln S. Smith,Mark W Tenforde,Christopher L. Carroll,Becky J. Riggs,Shira J. Gertz,Ariel Daube,Amanda N Lansell,Alvaro Coronado Munoz,Charlotte V. Hobbs,Kimberly Marohn,Natasha B. Halasa,Manish M. Patel,Manish M. Patel,Adrienne G. Randolph +47 more
TL;DR: Multisystem inflammatory syndrome in children associated with SARS-CoV-2 led to serious and life-threatening illness in previously healthy children and adolescents.
Journal ArticleDOI
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19.
Leora R. Feldstein,Leora R. Feldstein,Mark W Tenforde,Kevin G. Friedman,Margaret M Newhams,Erica Billig Rose,Erica Billig Rose,Heda Dapul,Vijaya L. Soma,Aline B Maddux,Peter M. Mourani,Cindy Bowens,Mia Maamari,Mark W. Hall,Becky J. Riggs,John S. Giuliano,Aalok R. Singh,Simon Li,Michele Kong,Jennifer E. Schuster,Gwenn E. McLaughlin,Stephanie P Schwartz,Tracie C. Walker,Laura Loftis,Charlotte V. Hobbs,Natasha B. Halasa,Sule Doymaz,Christopher Babbitt,Janet R. Hume,Shira J. Gertz,Katherine Irby,Katharine N. Clouser,Natalie Z. Cvijanovich,Tamara T. Bradford,Lincoln S. Smith,Sabrina M. Heidemann,Sheemon P. Zackai,Kari Wellnitz,Ryan Nofziger,Steven M. Horwitz,Ryan W. Carroll,Courtney M. Rowan,Keiko M. Tarquinio,Elizabeth H. Mack,Julie C. Fitzgerald,Bria M. Coates,Ashley M. Jackson,Cameron C. Young,Mary Beth F. Son,Manish M. Patel,Manish M. Patel,Jane W. Newburger,Adrienne G. Randolph +52 more
TL;DR: In this article, the authors compared clinical characteristics and outcomes of children and adolescents with MIS-C vs those with severe coronavirus disease 2019 (COVID-19) at 66 US hospitals in 31 states.
Journal ArticleDOI
Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series
Peter A. Nigrovic,Melissa L. Mannion,Femke H. M. Prince,Andrew Zeft,C. Egla Rabinovich,Marion A J van Rossum,Elisabetta Cortis,Manuela Pardeo,Paivi Miettunen,Ginger Janow,James Birmingham,Aaron Eggebeen,Erin Janssen,Andrew I. Shulman,Mary Beth F. Son,Sandy D. Hong,Karla N. Jones,Norman T. Ilowite,Randy Q. Cron,Gloria C. Higgins +19 more
TL;DR: Anakinra as first-line therapy for systemic JIA was associated with rapid resolution of systemic symptoms and prevention of refractory arthritis in almost 90% of patients during the interval examined.
Journal ArticleDOI
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 2.
Lauren A. Henderson,Scott W. Canna,Kevin G. Friedman,Mark Gorelik,Sivia K. Lapidus,Hamid Bassiri,Edward M. Behrens,Anne Ferris,Kate F. Kernan,Grant S. Schulert,Philip Seo,Mary Beth F. Son,Adriana H. Tremoulet,Rae S. M. Yeung,Amy S. Mudano,Amy S. Turner,David R. Karp,Jay J. Mehta +17 more
TL;DR: To provide guidance on the management of Multisystem Inflammatory Syndrome in Children (MIS‐C), a condition characterized by fever, inflammation, and multiorgan dysfunction that manifests late in the course of severe acute respiratory syndrome coronavirus 2 (SARS–CoV‐2) infection.
Journal ArticleDOI
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 1.
Lauren A. Henderson,Scott W. Canna,Kevin G. Friedman,Mark Gorelik,Sivia K. Lapidus,Hamid Bassiri,Edward M. Behrens,Anne Ferris,Kate F. Kernan,Grant S. Schulert,Philip Seo,Mary Beth F. Son,Adriana H. Tremoulet,Rae S. M. Yeung,Amy S. Mudano,Amy S. Turner,David R. Karp,Jay J. Mehta +17 more
TL;DR: A multidisciplinary task force was convened by the American College of Rheumatology (ACR) to provide guidance on the management of multisystem inflammatory syndrome in children (MIS-C), a condition characterized by fever, inflammation, and multiorgan dysfunction that manifests late in the course of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.